Symbol="ADXN"
AssetType="Common Stock"
Name="Addex Therapeutics Ltd"
Description="Addex Therapeutics Ltd, a developing-stage biopharmaceutical company, discovers, develops and markets small molecule pharmaceuticals for central nervous system (CNS) disorders in Switzerland. The company is headquartered in Geneva, Switzerland."
CIK="1574232"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="CHEMIN DES MINES 9, GENEVA, CH"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="8307400"
EBITDA="-12737369"
PERatio="None"
PEGRatio="None"
BookValue="0.492"
DividendPerShare="0"
DividendYield="0"
EPS="-1.36"
RevenuePerShareTTM="0.216"
ProfitMargin="0"
OperatingMarginTTM="-5.87"
ReturnOnAssetsTTM="-0.773"
ReturnOnEquityTTM="-1.977"
RevenueTTM="2148600"
GrossProfitTTM="1445000"
DilutedEPSTTM="-1.36"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="2.39"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.28"
PriceToBookRatio="1.409"
EVToRevenue="2.539"
EVToEBITDA="-0.147"
Beta="1.636"
num_52WeekHigh="2.28"
num_52WeekLow="0.422"
num_50DayMovingAverage="0.559"
num_200DayMovingAverage="0.85"
SharesOutstanding="15879300"
DividendDate="None"
ExDividendDate="None"
symbol="ADXN"
open="0.47"
high="0.49"
low="0.46"
price="0.48"
volume="26835.00"
latest_trading_day="2023-08-30"
previous_close="0.49"
change="-0.01"
change_percent="-1.2245%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="253772"
Change_recent_avg="-0.01"
Delta_recent_avg="0.06"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-1.68"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="162"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0014.jpeg"
image_negative_thumbnail_id_2="140"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0036.jpeg"
image_neutral_thumbnail_id_1="549"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_neutral_thumbnail_id_2="554"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_positive_thumbnail_id_1="618"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0090.jpeg"
image_positive_thumbnail_id_2="603"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0105.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
